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Members of the transforming growth factor-b (TGF-b) superfamily are critical regulators for epithelial growth and can alter
the differentiation of keratinocytes. Transduction of TGF-b signaling depends on the phosphorylation and activation of
Smad proteins by heteromeric complexes of ligand-specific type I and II receptors. To understand the function of TGF-b and
ctivin-specific Smad, we generated transgenic mice that overexpress Smad2 in epidermis under the control of keratin 14
romoter. Overexpression of Smad2 increases endogenous Smad4 and TGF-b1 expression while heterozygous loss of Smad2
educes their expression levels, suggesting a concerted action of Smad2 and -4 in regulating TGF-b signaling during skin
evelopment. These transgenic mice have delayed hair growth, underdeveloped ears, and shorter tails. In their skin, there
s severe thickening of the epidermis with disorganized epidermal architecture, indistinguishable basement membrane, and
ermal fibrosis. These abnormal phenotypes are due to increased proliferation of the basal epidermal cells and abnormalities
n the program of keratinocyte differentiation. The ectodermally derived enamel structure is also abnormal. Collectively,
ur study presents the first in vivo evidence that, by providing an auto-feedback in TGF-b signaling, Smad2 plays a pivotal
ole in regulating TGF-b-mediated epidermal homeostasis. © 2001 Academic Press
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a
tINTRODUCTION
The transforming growth factor-b (TGF-b) family in-
ludes a large number of structurally related polypeptide
rowth factors, each capable of regulating a fascinating
rray of cellular processes, including cell proliferation,
ineage determination, differentiation, and apoptosis.
GF-b signaling occurs through ligand-initiated hetero-
eric complex formation of type II and type I receptors
ith serine/threonine-kinase activity. The activated TGF-b
receptor then propagates the signal through transient inter-
1 To whom correspondence should be addressed. Fax: (323) 442-
2981. E-mail: ychai@hsc.usc.edu.
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All rights of reproduction in any form reserved.ction with, and phosphorylation of, TGF-b pathway-
restricted Smad2 and Smad3 proteins. Smad4, a common
Smad for all members of the TGF-b family, forms hetero-
oligomeric complexes with phosphorylated Smad2 or
Smad3. Subsequently, the Smad complexes translocate into
the cell nucleus, regulate the expression of transcription
factors, and affect the transcriptional status of target genes
(Massague, 1998).
TGF-b is an important regulator for skin development
nd maintenance of tissue homeostasis. Like its function in
he development of many organs, TGF-b often has opposite
effects on different cell types. In the epidermis of skin, cell
division is usually restricted to the basal layer, whereas
cells in the suprabasal layers are going through the process
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182 Ito et al.of terminal differentiation as they move toward the surface.
TGF-b is a potent epithelial growth inhibitor and can alter
differentiative properties of keratinocytes (Tucker et al.,
1984; Shipley et al., 1986; Reiss and Sartorelli, 1987; Fuchs,
1990; Fowlis et al., 1996; Wang et al., 1997). In the dermis,
however, TGF-b acts as a positive growth factor, inducing
the synthesis of extracellular matrix proteins during wound
healing (Roberts et al., 1986; Pittelkow et al., 1988; Sporn
and Roberts, 1992; Foitzik et al., 1999). In another well-
studied organogenesis model, tooth development is initi-
ated at the specified oral ectoderm and depends on contin-
ued epithelial–mesenchymal interaction that is mediated
by growth and transcription factors. Among them, TGF-b
acts as an inhibitor of enamel organ epithelial cell prolif-
eration while promoting extracellular matrix formation and
differentiation of mesenchymally derived preodontoblasts
(Chai et al., 1994, 1999; Thesleff and Sharp, 1997; D’Souza
et al., 1998; Unda et al., 2000). Elucidation of the molecular
echanism of control of epithelial homeostasis by TGF-b is
herefore critical to our understanding of the dynamic
olecular regulatory mechanism during ectodermally de-
ived organogenesis.
Studies on TGF-b and TGF-b receptor transgenic mice
ave supported the concept that TGF-b is primarily an
ectodermal growth inhibitor both in vivo and in vitro
(Sellheyer et al., 1993; Fowlis et al., 1996; Wang et al.,
1997). The discovery of Smad proteins has clearly advanced
our understanding on how TGF-b signaling is related from
its cognate receptor to the nucleus. In particular, Smad2 and
Smad3 are mediators of TGF-b and activin signals. Targeted
mutations of Smad gene have revealed important biological
functions of Smads in regulating embryogenesis. Smad2-
deficient mouse embryos fail to form an organized egg
cylinder and lack mesoderm (Nomura and Li, 1998; Waldrip
et al., 1998; Weinstein et al., 1998). In contrast, Smad3,
thought to act downstream in the TGF-b/activin signaling
athway, is not essential for embryonic development. In-
tead, adult Smad3-null mutant mice develop immunologi-
al defects and colon tumors (Zhu et al., 1998; Yang et al.,
999; Datto et al., 1999). When Smad4 was mutated, mouse
mbryos died shortly after implantation due to defects in
rimitive endoderm formation (Yang et al., 1998; Sirard et
l., 1998). Moreover, all Smad proteins are highly conserved
cross species and there are possible regulatory interactions
mong different Smads in transducing TGF-b signal. But,
because of the early embryonic lethality of Smad-null
mutation (e.g., Smad22/2), it is desirable to generate tissue-
specific alteration of Smad expression in order to investi-
gate the function of Smad during organogenesis.
Here, we investigated the functional role of Smad2 in
regulating ectodermally derived organogenesis by using
keratin 14 (K14) promoter. Overexpression of Smad2 target-
ing the basal layer of ectoderm affected the proliferation and
differentiation of epidermal keratinocytes. Interestingly,
endogenous levels of Smad4 were altered based on the
availability of Smad2, hence suggesting a concerted action
of these two Smads in regulating TGF-b-mediated ectoder- i
Copyright © 2001 by Academic Press. All rightmal homeostasis. Finally, these transgenic mice also
showed an increase of endogenous TGF-b1 expression in
he skin, indicating the positive impact on TGF-b signaling
by Smad2 overexpression.
MATERIALS AND METHODS
Plasmid Constructs and Generation of Transgenic
Mice
Human keratin 14 (K14) promoter-driven mouse Smad2-
encoding transgene was prepared as follows: an EcoRI–XhoI
lunted fragment (1.5 kb) encoding mouse Smad2 was subcloned
nto the BamHI blunted sites of the pGEM 3Z-K14 vector to
roduce pG3ZK14-Smad2. This construct thus contained a K14
romoter (2.1 kb), the b-globin intron (736 bp), the coding sequence
or Smad2 (1.5 kb), and K14 polyadenylation signal (500 bp). An
coRI–HindIII (4.7 kb) fragment was isolated free of vector se-
uence by preparative gel electrophoresis. DNA was further puri-
ed by using an Elutip column (Schleicher and Schuell, Dessell,
ederal Republic of Germany) and microinjected in the pronuclei of
ertilized oocytes (Jackson/B6D2F F1) by standard procedure.
Identification of Smad2 Transgenic and Mutant
Mice
Transgenic founder mice were identified by Southern blot anal-
ysis of DNA obtained from the tails. Tails were lysed with 100 mM
Tris–HCl, pH 8.5, 5 mM EDTA, pH 8.0, 0.2% SDS, 200 mM
NaCl/proteinase K, and then treated with phenol/chloroform, 1:1
(by volume), precipitated with ethanol, and dissolved in TE buffer
(10 mM Tris–HCl, pH 7.5/1 mM EDTA). After transfer to nylon
membranes (Dupont N1), Southern hybridization was performed
by using probes labeled with 32P of K14 gene by random priming.
or PCR analysis, tail genomic DNAs (0.5–1 mg) were submitted to
35 cycles of amplification (with each cycle consisting of 94°C,
62°C, 72°C, 1 min for each) on a thermal cycler. An aliquot (15 ml)
of each reaction was resolved in a 1% agarose gel, and amplified
fragments were visualized by ethidium bromide staining. The PCR
primers used here were 59-ACA CCT CCA AAG CAG GAC CAA
GTG G-39 and 59-ATT TAC GCC TCT GTG ACC CAG GGC
TTC-39. The PCR product size was 487 bp. Genotypes of Smad2
and Smad3 mutant mouse embryos were determined by PCR as
previously described (Weinstein et al., 1998; Yang et al., 1999).
RNA Isolation and Northern Blot
Total cellular RNA was prepared by following the RNA isolation
method (TRIzol, GIBCO BRL) developed by Chomczynski and
Sacchi (1987). The total RNA was further purified by using RNeasy
Kits (Qiagen). Aliquots of the total RNA were electrophoresed in
1% agarose gels. Subsequently, the samples were transferred to
nylon filters (Hybond-N; Micron Separations Inc.) by electroblot-
ting. Filters were prehybridized for 4 h at room temperature. Each
cDNA was labeled by random primer method using the NEBlot kit
(New England Biolabs Inc.) and [a-32P]dCTP (NEN Life Science
roducts). Hybridization was performed at 65°C overnight by using
he ExpressHyb hybridization solution (Clontech, Palo Alto, CA).
ilters were washed twice in 23 SSC, 0.1% SDS for 15 min at 55°C,
hen in 13 SSC, 0.1% SDS for 20 min at 55°C. Washed filters were
xposed to x-ray film at 280°C for various lengths of time depend-
ng upon the intensity of the signal.
s of reproduction in any form reserved.
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183Overexpression of Smad2 and Epidermal HomeostasisWestern Blot Analysis
The BMP2/4 antibody (Santa Cruz Biotechnology, Santa Cruz,
CA), Smad2, Smad4 antibodies (Transduction Laboratories), Smad3
antibody (Zymed, South San Francisco, CA), and TGF-b1 antibody
R & D Systems) were used for Western analysis as previously
escribed (Chai et al., 1999). b-Actin was used as internal control.
Histological Analysis
Mouse tails, incisors, and skin were fixed in 10% buffered
formalin overnight at 4°C and embedded in paraffin. Tissue sec-
tions (6 mm) were stained with hematoxylin–eosin.
Evaluation of DNA Synthesis Activity in the Skin
Mice were injected (i.p.) with BrdU (5-bromo-29-deoxy-uridine;
Sigma) at 100 mg/kg body weight and sacrificed 3 h after injection.
Tail specimen were harvested and fixed in Carnoy’s solution for
immunostaining (Chai et al., 1998). Ten sections of tail skin were
andomly selected from each mouse to evaluate the number of
rdU-labeled cells in the epidermis. Four Smad2 transgenic mice
nd four wild-type littermates were used for this analysis.
In Situ Hybridization
Both Smad2 and TGF-b RNA probes were labeled with Fluores-
cein labeling mix (Boehringer Mannheim). Tail-skin sections from
wild-type and K14-Smad2Tg/1 were mounted on the same slide to
ensure equal exposure to the probes. Hybridization was performed
as previously described (Zhao et al., 1996). Positive signal was
shown as green fluorescence in dark field.
Immunohistochemistry
Mouse tail skin was obtained from control and Smad2 transgenic
mice and was processed according to standard procedures (Chai et
l., 1999). Serial sections (6 mm) of control and Smad2 transgenic
ouse tail were cut and mounted onto the same slide to ensure
qual exposure to the same antibody concentration. The following
ntibodies were used for immunostaining: anti-Smad2 (1:100)
Transduction Laboratories); anti-BrdU (1:200); anti-K14 (1:100);
nti-laminin (1:50) (Sigma–Aldrich); anti-loricrin (1:2000); anti-
laggrin (1:1000) (BabCo); anti-K10 (1:100) (Dako); anti-TGF-b1
(1:100) (R & D Systems); and anti-fibronectin (1:100) (Santa Cruz
Biotechnology).
Scanning Electron Microscopy
Mouse-tissue specimen were processed and viewed according to
standard procedures (Chai et al., 1997).
RESULTS
Generation of Transgenic Mice with Targeted
Expression of Smad2 to Basal Keratinocytes
A 4.9-kb K14-Smad2 gene construct was generated (Fig.
1A) to target Smad2 expression to the basal keratinocytes of
transgenic mice. Human K14 promoter has successfully
Copyright © 2001 by Academic Press. All rightargeted gene expression to the basal compartment of the
pidermis and to the outer root sheath of hair follicles
Vassar et al., 1989; Byrne et al., 1994; Gat et al., 1998). The
purified transgene was microinjected into the pronuclei of
fertilized eggs harvested from C57BL6/J 3 CBA/J mice.
FIG. 1. Transgene construct and expression. (A) Schematic draw-
ing shows the structure of K14-Smad2 transgenic construct. PCR
primers were designed to amplify human K14 promoter (1026–
1510) for genotyping transgenic mice. (B) Northern analysis of
Smad2 mRNA expression in different tissues of wild-type (wt) and
transgenic mice (tg/1). The expression of Smad2 transgene was
detected in the tail, tongue, and skin but not in liver and lung of
2-wk-old transgenic mice. The transgene expression pattern faith-
fully correlated with the in vivo activity and specificity of human
-14 promoter. The endogenous Smad2 expression was not seen in
he wild-type tissue sample because the amount of total RNA
oaded in each lane (20 mg) was not sufficient for endogenous
mad2 to be detected. (C) The amount of Smad2 transgene expres-
ion was correlated with the severity of phenotype of Smad2
ransgenic mice. Fifteen micrograms of total RNA were loaded in
ach lane. Lane 1, wild-type littermate. Lane 2, lower level Smad2
ransgene expression was associated with less severe skin pheno-
ype. Lane 3, higher level of Smad2 transgene expression was
orrelated with severe skin phenotype (see Figs. 3 and 4). Lane 4,
mad2 heterozygous mutant. Overexpression or underexpression
f Smad2 did not affect the endogenous Smad3 expression, as
ndicated by using tail samples (2 weeks postnatal) from wild-type
wt), K14-Smad2 overexpression transgenic (tg/1), and Smad2 het-
rozygous mutant (1/2) mice. Overexpression of Smad2 (tg/1)
levated the endogenous TGF-b1 expression while it remained
undetectable in the wild-type littermate.Southern blot analysis identified three founder mice and
s of reproduction in any form reserved.
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184 Ito et al.their transgenic lines. Two of the three lines exhibited
identical phenotypes, with descendents of one line showing
more severe defects than the ones of the other line. In
particular, Smad2 transgenic mice had defects in the skin,
hair, tail, tongue, ear, and overall size of the body (see Figs.
3 and 4). Because we successfully obtained two lines of
Smad2 transgenic mice, we were confident that the ob-
served phenotypes could be attributed to Smad2 transgene
expression and not chromosomal integration site.
The expression of human keratin 14 gene is tissue-
specific and differentiation-specific in transgenic mice (Vas-
sar et al., 1989). Here, we demonstrated that K14-Smad2
transgene was expressed in the tail, tongue, and skin, but
not in liver and lung (Fig. 1B), completely matched with the
tissue-specificity of K14-driven transgene expression in
mice. When we examined the Smad2 transgene expression
level in the two different lines of transgenic mice, it was
apparent that a higher level of Smad2 expression was
FIG. 2. Western analysis showing overexpression of Smad2 in
alteration of Smad2 expression. (A) Lane 1, wild-type mouse tail. L
appearance). Lane 3, K14-Smad2 transgenic mouse tail (with severe
K-14-Smad2 transgenic mice showed a significant increase in Sma
the endogenous Smad2 expression. Interestingly, either over- (Sm
endogenous Smad3 expression. Because of the overwhelming prod
with Smad2 by showing an extra band above the Smad3 in transgen
the overexpression of Smad2 in the transgenic mice while negat
mutant. b-Actin was used as a loading standard. Densitometric ana
when compared to the wild-type control (as 100%). Each bar repr
transgenics (labeled as 2 and 3) are correlated with lanes 2 and 3 m
Overexpression of Smad2 (tg/1) increased TGF-b1 expression i
xpression. The expression of BMP2/4 was not affected by the dosag
f TGF-b1 expression when compared with the wild-type control (associated with more severe phenotypes (Fig. 1C). i
Copyright © 2001 by Academic Press. All rightBecause of the high homology between Smad2 and
mad3, we examined the endogenous Smad3 expression.
here was no alteration of Smad3 expression level in either
14-Smad2 transgenic or Smad2 heterozygous knockout
which were maintained on the same genetic background as
he transgenic and tissue samples were collected from
ewborn Smad21/2 mutant) mice (Fig. 1C).
When we examined the protein expression levels, we
ound that there was also variation in the overexpression
f Smad2 (Fig. 2A), which was correlated with the severe-
ess of macroscopic phenotypes. In particular, there was
5-fold increase of Smad2 expression in K14-Smad2 mice
ith less severe phenotypes and more than 10-fold in-
rease on Smad 2 in transgenic mice with severe pheno-
ypes (Fig. 2A). The difference of phenotype severeness
as only quantitative (such as the thickness of epider-
is), but not qualitative, between the two lines of
ransgenic mice. When we examined Smad2 expression
genic mice and changes of Smad4 expression resulted from the
2, K14-Smad2 transgenic mouse tail (with less severe phenotypic
malformation). Lane 4, Smad21/2 heterozygous mutant mouse tail.
pression, while heterozygous loss of Smad2 significantly reduced
g/1) or under- (Smad21/2) expression of Smad2 did not affect the
n of Smad2 in the transgenic mice Smad3 antibody cross-reacted
mples. Endogenous Smad4 expression was positively regulated by
regulated by the underexpression of Smad2 in its heterozygous
(on the right) indicated the relative amount of protein expression
ts the mean and SD of at least 14 samples. The two K14-Smad2
ned above. (B) The dosage of Smad2 regulated TGF-b1 expression.
skin while underexpression of Smad2 (1/2) reduced TGF-b1
mad2. Densitometric analysis (right) indicated the relative amount
0%). Each bar represents the mean and SD of at least 14 samples.trans
ane
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185Overexpression of Smad2 and Epidermal Homeostasisthe endogenous Smad2 expression level when compared
to the wild-type littermates (Fig. 2A).
Smad4, but Not Smad3, Is Induced in Response to
Smad2 Overexpression while Heterozygous Loss of
Smad2 Reduces Smad4 Expression
Both TGF-b and activin engage their receptors that
phosphorylate Smad2 and Smad3. Phosphorylated Smad2
and Smad3 associate with Smad4 for the assembly of
transcriptional complex that is then transported into the
nucleus for TGF-b target gene regulation (Massague et
l., 2000). Endogenous Smad3 expression was not affected
n either Smad2 transgenic overexpression or Smad2
eterozygous mutant mice (Fig. 2A). Interestingly, endog-
nous Smad4 expression directly correlated with the
evel of Smad2. In K14-Smad2 transgenic mice, endoge-
ous Smad4 showed significant (P , 0.05) increases,
ith a correlation to the intensity of Smad2 overexpres-
ion. Evaluating the Western analysis results from 14
ifferent K14-Smad2 transgenic mice, densitometric
nalysis indicated that the average endogenous Smad4
ncreased by 2- to 3-fold compared with the wild-type
ontrol (Fig. 2A). Meanwhile, heterozygous loss of Smad2
n 5 18) significantly (P , 0.05) reduced endogenous
mad4 expression to about 65% of the wild-type control
evel (Fig. 2A). Collectively, there is an apparent direct
orrelation between levels of Smad2 and Smad4 in regu-
ating TGF-b signals in the skin.
Overexpression of Smad2 Positively Regulates
Endogenous TGF-b1 Expression
TGF-b1 and its type II receptor are part of the endogenous
omeostatic regulatory machinery of the epidermis. Over-
xpression of TGF-b1 in the epidermis resulted in the
elevation of its type II receptor expression, indicating their
concerted action during TGF-b signaling (Cui et al., 1995).
Here, we examined the possible feedback on endogenous
TGF-b1 expression by its signaling molecule Smad2. Over-
xpression of Smad2 elevated the endogenous TGF-b1 level
hile heterozygous loss of Smad2 reduced TGF-b1 expres-
ion (Figs. 1C and 2B). Densitometric analysis indicated
hat Smad2 overexpression resulted in a twofold increase of
ndogenous TGF-b1 expression while haploinsufficiency of
Smad2 reduced TGFb1 by about 50%. To further examine
the specificity of TGF-b signaling Smad on other members
of the TGF-b superfamily, we evaluated the expression of
BMP2 and -4 in both Smad2 transgenic and heterozygous
knockout mice and did not see any alteration of BMP
expression (Fig. 2B), indicating that the positive feedback on
endogenous TGF-b expression by Smad2 was pathway-
specific.
Copyright © 2001 by Academic Press. All rightThe Severity of Phenotypes of Transgenic Mice Is
Correlated with the Level of Smad2
Overexpression
At birth, macroscopic phenotypes of transgenic mice were
only observed in about 20% of pups (n 5 235) with short/
necrotic tip of tail. Despite strong transgene activity by E14,
the remaining transgenic mice did not show overt phenotypes
until 10–14 days after birth. They appeared small, with the
most severely affected ones only half the size, compared with
their wild-type littermates (Fig. 3A). Both front and hind paws
showed thickened and flaky skin surface compared with the
controls (Figs. 3B and 3C). The skin defects of these transgenic
mice varied from macroscopically normal to severely flaky
with sparse hair, especially at the ventral surface of transgenic
FIG. 3. Macroscopic phenotypes of the Smad2 overexpressing mice.
Two-week-old wild-type and transgenic littermates are shown here.
(A) Strikingly, the K14-Smad2 transgenic mice (represented by the one
on the left) were about one-half the size of their wild-type littermates
(shown on the right) and remained to be small until adulthood (3
months). (B, C) Apparent skin defect was present in these transgenic
mice. Thick, flaky, and tight skin surface was apparent in the paws of
transgenic mice (C), when compared to the control (B). In addition to
the skin defect, the hair development was also disturbed in these
transgenic mice. (D) Normal hair distribution was shown at the
ventral surface of a wild-type mouse. (E) In the Smad2 transgenic
animal, the hyperkeratinized (with shiny appearance) ventral skin
surface was covered with sparse hair. (F) In the wild-type littermates,
ear development was normal with an elongated pinna (inset). (G) In
Smad2 transgenic animals, pinna development was severely retarded
(inset) and the skin surrounding the pinna was flaky.animal (Fig. 3E). In addition, these mice had smaller ears (Fig.
s of reproduction in any form reserved.
staining was used to evaluate the integrity of basement membrane.
186 Ito et al.
Copyright © 2001 by Academic Press. All right3G), compared with their wild-type littermates (Fig. 3F). When
examined closely, the rudiment of external ear was present
but failed to develop (Fig. 3G, inset). The severity of macro-
scopic phenotypes correlated with the level of Smad2 trans-
gene expression, with almost no macroscopic alterations in
transgenic mice that expressed very low level of Smad2
transgene.
Distinctive features of these transgenic mice were the
short tail and flaky skin at 2 weeks after birth (Figs. 4A and
4B). Significant histological changes in the tail skin were
observed in both lines of transgenic mice. The epidermis of
transgenic mice was much thicker (Fig. 4D) compared with
the skin of controls (Fig. 4C). The basement membrane was
irregular and not well defined (Fig. 4D, arrow) and the
epidermal architecture was highly disorganized. In addi-
tion, there were fewer hair follicles (P , 0.05) in the
transgenic mice. The subcutaneous fatty tissue, which was
normally present in the controls (Fig. 4C), was replaced by
fibrous connective tissue in K14-Smad2 mice (Fig. 4D).
These skin defects were also associated with the body skin
and ear. When we examined the different cellular layers of
epidermis, we found that there was disorganization of the
basal layer and thickening of the suprabasal layer (Fig. 4F).
Unlike the controls (Fig. 4E), extra granular cell layers were
also present in these transgenic mice (Fig. 4F). At the skin
surface, there was significant increase in thickness of stra-
tum corneum (8 to 10 times thicker). To further analyze the
integrity of basement membrane, we examined the expres-
sion of laminin. In the control, a well-defined and continu-
ous laminin expression was present at the basement mem-
brane (Fig. 4G, arrow). In K14-Smad2 mice, the basement
membrane was interrupted as indicated by the pattern of
laminin expression (Fig. 4H). As these transgenic animals
grew older, their macroscopic phenotypes gradually became
less obvious, although both ears and tails remained abnor-
mal. At 9 months, hyperkeratinized epidermis was still
observed in the tail skin (Fig. 4J).
Smad2 Transgene Expression in Epidermis, Its
Effects on Keratinocyte Proliferation and
Differentiation
TGF-b regulates keratinocyte proliferation and differen-
tiation in skin. Endogenous Smad2 expression in the epi-
(G) In the control, laminin expression indicated a well-defined and
continuous basement membrane (arrow). Anti-laminin antibody
also stained blood vessels (bv) in dermis. (H) In K14-Smad2 trans-
genic mice, the basement membrane (indicated by the white dotted
line) was not well defined and discontinuous (arrow). Anti-laminin
antibody also cross-reacted with the increased fibrous tissue in
dermis (d). (I, J) The architectural alteration in epidermis persisted
in the tail skin of 9-month-old transgenic mice (J) when compared
with their wild-type littermate (I). Arrow points to basementFIG. 4. Histological changes in Smad2 transgenic mouse tail skin.
(A) Compared with its wild-type littermates, the tail of the Smad2
transgenic mouse was significantly shorter (lower mouse). (B)
When examined closely, there was severe tail malformation in the
transgenic animal, with apparent flaky and cracked skin surface.
(C, E) Histology of tail skin from a 2-wk-old wild-type littermate
mouse. The basement membrane (arrow) was well defined and
there were very few suprabasal and granular cell layers in the
epidermis (e). (D and F) In Smad2 transgenic mice (littermates of
the wild-type control), the architecture of epidermis was severely
disturbed. The basement membrane became undefined (arrow).
There were more suprabasal and granular cell layers in the epider-
mis and a severe thickening of the stratum corneum. Interestingly,
there was also alteration of the dermis structure. In the control
littermates, fatty tissue was localized under the dermis (* in C),
while it was replaced by connective tissue in the transgenic animal
(* in D). Additionally, Smad2 transgenic mice had fewer hair
follicles compared with their wild-type littermates. Anti-lamininmembrane. e, epidermis.
s of reproduction in any form reserved.
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187Overexpression of Smad2 and Epidermal Homeostasisdermis has been demonstrated and may be altered in
epithelial skin tumors (Dick et al., 1998; Lange et al., 1999).
ence, we examined the Smad2 expression and keratino-
yte proliferation as well as differentiation in our transgenic
ice. K14-Smad2 transgenic mice revealed strong expres-
ion of Smad2 throughout the epidermis (Fig. 5B), providing
he physical evidence that overexpression of Smad2 might
e responsible for both macroscopic and microscopic
hanges in the skin. In the wild-type control, however,
here was very low level of endogenous Smad2 expression
n the epidermis while most of the Smad2 was localized to
ermis (Fig. 5A). Furthermore, phosphorylated Smad2 was
ocalized within keratinocyte nuclei throughout all layers
f epidermis (Fig. 5B inset), indicating that the overex-
ressed Smad2 was able to be phosphorylated, translocate
nto the nuclei, and regulate TGF-b target gene expression.
e also examined localization of Smad2, Smad3, and
mad4 mRNA in the skin. There was a very low level of
mad2 expression in basal layer of epidermis and diffused
xpression in dermis (Fig. 5A9) in the control sample while
here was a significant increase in Smad2 expression in the
pidermis of transgenic mice (Fig. 5B9). Expression of Smad4
RNA was significantly expanded throughout all layers of
pidermis in the transgenic mice (Fig. 5B0), while it was at
very low level in the control sample (Fig. 5A0), indicating
hat overexpression of Smad2 up-regulated the expression
f Smad4 in epidermis. There was no difference in Smad3
xpression pattern in epidermis between wild-type control
nd Smad2 transgenic mice (data not shown).
BrdU incorporation analysis revealed that overexpression
f Smad2 significantly increased the proliferation (P ,
.05) of basal layer keratinocytes (Fig. 5D) when compared
o the control group (Fig. 5C). To examine the terminal
ifferentiation of keratinocytes in transgenic mice, we used
everal keratinocyte differentiation-specific markers. Lori-
rin is a major component of the cornified envelope in the
ranular layer of epidermis (Fuchs, 1990, and references
herein). In the control sample, loricrin expression was
onfined to one or two cell layers in granular layer of
pidermis (Fig. 5E), while it was expressed through seven to
ight cell layers in the transgenic mice (Fig. 5F). Addition-
lly, filaggrin, another granular layer-specific protein, was
lso widely expressed through multilayers of epidermis in
he Smad2 transgenic mice (Fig. 5F, inset). The normal
pidermis usually has four to eight layers of suprabasal
pinous cells that are postmitotic, but metabolically active
nd produce two new keratins (K1 and K10). In the control
amples, K10 was localized to the suprabasal spinous cells,
ut not in the basal layer of epidermis (Fig. 5G). In the
ransgenic mice, K10 expression was found in all layers of
he expanded stratum spinosum, with some of the basal
ayer cells also showing positive staining (Fig. 5H). The
asal layer of epidermis has the capacity of DNA synthesis
nd mitosis. These cells produce two distinct keratin pro-
eins (K5 and K14). K14 was exclusively expressed in the
ingle basal cell layer of epidermis in the wild-type control
Copyright © 2001 by Academic Press. All rightFig. 5I). In K14-Smad2 mice, K14 was expressed in basal,
uprabasal, and granular layers of epidermis (Fig. 5J).
Because our transgenic construct targeted the basal layer
f epidermis, we examined the downstream effects of
mad2 overexpression, which might be responsible for the
tructural changes in dermis (Fig. 4D). TGF-b expression
has been shown to be up-regulated in an autoregulatory
fashion (van Obberghen-Schilling et al., 1988; Bascom et al.,
1989). Hence, we examined the expression of TGF-b in
K14-Smad2 mice. There was a twofold increase of endoge-
nous TGF-b1 expression in K14-Smad2 mice (Figs. 1C and
B). Immunolocalization analysis showed that TGF-b1 was
xpressed at a very low level in the dermis in the control
ice (Fig. 6A), while it was highly expressed in both the
pidermis and dermis of transgenic mice (Fig. 6B). This
bservation was further supported by examining TGF-b1
mRNA expression, which was at a very low level in the
basal layer of epidermis (Fig. 6A9) in the control sample. In
Smad2 transgenic mice, TGF-b1 mRNA was detected
hroughout all layers of epidermis (Fig. 6B9). TGF-b1 is
nown to enhance the production of fibronectins, which are
mportant elements in connective tissue for cross-linking
o collagen (Vaughan et al., 2000). In Smad2 transgenic
ice, fibronectin expression was elevated in the dermis of
ransgenic mice (Fig. 6D), which provides potential expla-
ation for dermal fibrosis.
Smad2 Regulates Proper Enamel Formation
Smad2 is expressed during early tooth development and
may regulate ameloblast differentiation (Dick et al., 1998).
oth newly erupted upper and lower incisors appeared
halky-white and were frequently chipped in Smad2 trans-
enic mice (Fig. 7B), while the ones from wild-type litter-
ates appeared normal with a shiny and grayish enamel
urface (Fig. 7A). Additionally, the tongue was substantially
arger in the transgenic animal (Fig. 7B), which possibly
nterfered with food intake by these transgenic mice. The
ncisors had blunt tips while the molars had fewer and
nderdeveloped cusps in transgenic animal (Fig. 7D) when
ompared with the controls (Fig. 7C). In this study, we
ocused on the developmental analysis of incisors for the
ollowing reasons. First, rodent incisors continue to grow
hroughout life, which offers a good model to examine the
ontinued differentiation of ameloblasts that are targeted
y K14 promoter. Second, only the labial surface of rodent
ncisors is covered by enamel. Any alteration in the enamel
ormation can be easily monitored. Under the scanning
lectron microscope, the enamel surface of control incisors
ppeared smooth and the tip was pointed (Figs. 7E and 7G),
hile the incisor surface of transgenic mice was irregular
nd wavy and the tip was blunt (Figs. 7F and 7H). The
ifference of enamel surface topography between the wild-
ype and transgenic mice made it clear that the chalky-
hite appearance of transgenic incisors was due to light
eing scattered by the irregular enamel structure.
To evaluate the maturation and differentiation of amelo-
s of reproduction in any form reserved.
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188 Ito et al.blasts, we first compared the histological appearance of
these cells in both control and transgenic mice. In wild-type
mice, ameloblasts were well formed and arranged in an
orderly fashion (Fig. 8A). In Smad2 transgenic mice, amelo-
blasts appeared to be arranged in spiral fashion, which
resulted in the cross-sectional appearance (Fig. 8B). We then
examined the expression of amelogenin as a differentiation
marker for these ameloblasts. In a cross-section of lower
incisor, amelogenin was localized towards the anterior
portion of incisor in both wild-type and transgenic mice
(Figs. 8C and 8D). When examined closely, amelogenin was
secreted by the ameloblasts and deposited into the enamel
matrix at the apical surface of ameloblasts in the wild-type
mice (Fig. 8E). In transgenic mice, however, amelogenin
was localized between the ameloblasts (Fig. 8F), instead of
being in enamel matrix at the apical region of ameloblasts.
This inaccurate deposition of amelogenin may have inter-
fered with the enamel crystal structure build-up that ulti-
mately resulted in the irregular enamel surface in Smad2
transgenic mice. Amelogenin expression in the transgenic
mice, however, indicated that these ameloblasts were able
to terminally differentiate during tooth morphogenesis.
DISCUSSION
Through the generation of our K14-Smad2 transgenic
mice, we have learned that the concerted action of Smad2
and Smad4 is important in control of TGF-b-mediated
epidermal homeostasis. The level of Smad expression is
critical for the regulation of TGF-b signals. The receptor-
egulated Smad2 has an auto-feedback effect on TGF-b,
hich is ultimately responsible for regulating the prolifera-
ion and differentiation of keratinocyte as well as amelo-
last during epidermally derived organogenesis.
In order to attribute the phenotypes of transgenic mice to
he overexpression of Smad2, we first examined the local-
zation of Smad2. Both unphosphorylated and phosphory-
ated (PS2) Smad2 were localized throughout the epidermis,
ndicating that the overexpressed Smad2 was activated to
nitiate TGF-b-mediated genetic response. This PS2 anti-
ody has been used in various studies to demonstrate its
pecificity in recognizing the phosphorylated Smad2 upon
GF-b stimulation (Nakao et al., 1999; Stopa et al., 2000).
Second, we examined some of the possible target genes that
are regulated by the increased Smad2 expression. Smad4,
but not Smad3, was up-regulated in Smad2 overexpression
mice. In tandem, using samples from Smad2 heterozygous
mutant mice, we found that Smad4 was down-regulated
while the expression of Smad3 remained unaffected. This
observation suggests that TGF-b/activin signaling-specific
mad2 positively regulate the expression of Smad4 (the
ommon Smad), which mediates the signaling from diverse
embers of TGF-b superfamily, and this direct correlation
f Smad2 and Smad4 may play an important role in adjust-
ng different Smad pathways. In vitro studies have shown
hat Smad4 acts as a TGF-b-inducible DNA-binding protein
Copyright © 2001 by Academic Press. All rightnd is up-regulated by Smad2 overexpression (Yingling et
l., 1997; Li et al., 1998). Smad2 and Smad4 form het-
erodimers to regulate TGF-b-induced signaling and their
utations may cause carcinogenesis (Jayaraman and Mas-
ague, 2000; Tsujiuchi et al., 2000). The expanded expres-
ion of Smad4 (as demonstrated by in situ hybridization,
ig. 5B0) provides supportive evidence that the elevated
mad4 expression is the result of up-regulated Smad4 gene
xpression, not of delayed Smad4 degradation due to the
xcessive amount of Smad2 in our transgenic mice. Collec-
ively, these studies present an important relationship
etween Smad2 and Smad4, and our study here provides the
rst in vivo evidence of concerted action between Smad2
and Smad4 in regulating TGF-b-mediated epidermal ho-
meostasis.
Smad3 shares more than 95% homology with Smad2 but
they may function differently during embryonic develop-
ment (Baker and Harland, 1996; Wu et al., 1997; Nomura
and Li, 1998; Weinstein et al., 1998; Zhu et al., 1998; Yang
et al., 1999). In particular, Smad2 may play a more impor-
tant role in regulating embryonic development while
Smad3 is more involved in pathogenesis or the wound-
healing process (Ashcroft et al., 1999; Massague et al.,
2000). This argument is further supported by the Smad2-
and Smad3-null mutation studies, in which Smad22/2 mu-
ant is early embryonic lethal, while Smad32/2 mice de-
velop normally. On the other hand, an alternatively spliced
form of Smad2 can apparently substitute for the DNA
binding activities of and, therefore, function as Smad3 (Yagi
et al., 1999). In general, studies suggest that Smad2 and
Smad3 regulate distinct sets of target genes, although on
certain target they are possibly interchangeable (see review
by Massague et al., 2000).
Additional supportive evidence of overexpressed Smad2
capable of transducing TGF-b-mediated signaling was dem-
onstrated by the elevated expression of endogenous TGF-b1
n Smad2 transgenic mice. TGF-b1 has been shown to
increase steady-state levels of its own expression and to
affect the expression of its type II receptor (van Obberghen-
Schilling et al., 1988; Cui et al., 1995). Overexpression of
mad2 is colocalized with TGF-b1 expression in human
pancreatic cancer (Kleeff et al., 1999). Smad3 also appears to
be critical for the auto-induction of TGF-b in keratinocytes
nd macrophages (Ashcroft et al., 1999). Apparently, there
s a positive auto-feedback mechanism that regulates en-
ogenous TGF-b expression. Our study has demonstrated
hat the level of Smad2 expression is responsible for medi-
ting the auto-feedback on TGF-b signaling in epidermis in
cell-autonomous manner. We have also examined the
ndogenous TGF-b2 and -b3 expression in Smad2 trans-
genic mice and did not see any alteration (data not shown),
indicating the other isoforms of TGF-b may be less sensi-
tive to the level of Smad2 or they are less involved in
regulating the fate of epidermal keratinocytes.
A major function of TGF-b is to regulate the expression of
genes whose products contribute to building the ECM.
TGF-b1 stimulates the production of collagen and fibronec-
s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All righttin (Ignotz and Massague, 1987; Massague, 1990). In vitro
tudy shows that overexpression of Smad2 and Smad3
nhibits adipogenesis (Choy et al., 2000). Within the dermis,
ong-term stimulation by TGF-b or activin may gradually
lter extracellular matrix molecule metabolism and cause
he replacement of fatty tissue by connective tissue (Munz
t al., 1999). Targeted deletion of one allele of TGF-b
prevents the increase of skin thickness and reverses dermal
fibrosis in tight skin mice (McGaha et al., 2001). Epider-
mally synthesized TGF-b1 can certainly reach the dermis
and cause such paracrine effects (Fowlis et al., 1992). With
the discontinuous basement membrane, as demonstrated
by anti-laminin staining (Fig. 4H), it is easier for epider-
mally overproduced TGF-b1 to reach dermis. Hence, the
elevated TGF-b1 expression in the dermis is at least par-
tially responsible for the replacement of fatty tissue by
connective tissue (in a cell nonautonomous manner) in
K14-Smad2 mice. Further supportive evidence for diffusion
of TGF-b1 into the underlying mesenchyme in Smad2
ransgenic mice comes from the severely hypertrophic ear
artilage, which is a known effect of TGF-b or activin
Quatela et al., 1993; Munz et al., 1999).
Activin is a critical regulator for keratinocyte prolifera-
ion and differentiation as well as in dermal fibrosis and
utaneous wound repair. Overexpression of activin A in the
the dermis of tail skin. Noticeably, the basement membrane was
not well defined in the transgenic sample. Phosphorylated Smad2
was also detected in the nuclei of keratinocyte (arrows) throughout
all layers of epidermis (inset). (A9) Smad2 mRNA was present
mainly in the basal layer of epidermis (*) and as diffused expression
in the dermis of 2-week-old wild-type control sample. (B9) In Smad2
transgenic mice, Smad2 mRNA was detected throughout all layers
of epidermis with both cytoplasmic and nuclear localization (see
inset). (A0) Very low level of Smad4 mRNA was detected in the
suprabasal layer of epidermis (e) of wild-type control sample.
Nonspecific signal was observed within stratum corneum. White
dotted line marks the basement membrane. (B0) Smad4 mRNA
expression expanded throughout all layers of epidermis (especially
in suprabasal and granular layers) in transgenic mice. (C) Cell
proliferation analysis indicated that basal keratinocytes main-
tained a low level of DNA synthesis (arrow) in the control sample.
(D) In the Smad2 transgenic mice, there was a 3- to 4-fold increase
in the proliferation rate of basal keratinocytes. (E) Loricrin (Lori)
was localized to one to two layers of granular cells (*) in the control
epidermis. (F) In the transgenic sample, loricrin-expressing cells
had expanded to five to six layers in the epidermis. When we
examined the expression pattern of filaggrin (another granular cell
layer specific protein), it showed identical expression pattern (*) in
the granular layer comparing to loricrin expression (inset). (G) In
the control, cytokeratin 10 (K10) was expressed in the suprabasal
layer (*) of epidermis. (H) In Smad2 overexpressing transgenic
sample, K10 expression expanded throughout both suprabasal and
granular layers of epidermis. (I) Cytokeratin 14 (K14) was only
expressed in the basal keratinocytes of epidermis and hair follicles
(h) in the control. (J) In the transgenic sample, K14 expression hadFIG. 5. Overexpression of Smad2 affected proliferation and differ-
ntiation of keratinocytes in epidermis of transgenic mice. Positive
taining was shown in red. (A) At 2 weeks after birth, endogenous
mad2 (S2) was mainly localized in the dermis (d) and was almost
ot detectable in the epidermis (e) with the antibody concentration
sed here. The basement membrane (arrow, and references herein)
as well defined in the control tail sample. (B) In the Smad2
ransgenic mice, however, Smad2 was highly expressed throughout
spread into all layers of epidermis (*).
s of reproduction in any form reserved.
190 Ito et al.FIG. 6. Overexpression of Smad2 resulted in up-regulation of TGF-b1 and fibronectin expression in dermis of transgenic mice. Positive
staining was shown in red. (A) At 2 weeks after birth, TGF-b1 (b1) was mainly localized within the connective tissue under the tail skin.
Both epidermis (e) and dermis (d) had very low TGF-b1 expression in wild-type mice. (B) In Smad2 transgenic sample, strong TGF-b1
expression was localized in the epidermis, mainly in the suprabasal layer (*), and dermis. (A9) TGF-b1 mRNA was present (low level) in the
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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191Overexpression of Smad2 and Epidermal Homeostasisskin using the K14 promoter results in almost identical,
although less severe, phenotypes (Munz et al., 1999) when
ompared with our Smad2 transgenic mice. In this study,
e were not able to detect any alteration of endogenous
ctivin expression (mainly due to the nonspecificity of
ctivin antibody). However, given the phenotype similarity
etween our Smad2 and the activin transgenic mice, we
uggest that overexpression of signaling intermediate may,
o certain extent, mimic overexpression of ligands which
ctivate Smad2, including both activin and TGF-b. Further-
more, both Smad2 and Smad3 are the cognate Smad pro-
teins downstream of TGF-b as well as activin receptors.
Protein structural analysis has revealed, however, that
Smad2 and Smad3 behave differently in regulating the
transcription of a target gene. Smad3, but not Smad2, alone
can stimulate the transcriptional activity of the activin-
responsive element derived from Xenopus Mix.2 promoter
(Nagarajan and Chen, 2000). In human keratinocytes, ac-
tivin A preferentially activates Smad3 (Shimizu et al.,
1998), indicating that Smad3 may more preferentially regu-
late activin signals. Collectively, this information supports
the argument that different Smads may differentially regu-
late the different members of TGF-b family, as each one of
them exerts unique activities in the skin.
In reviewing both the macroscopic and microscopic phe-
notypes of K14-Smad2 transgenic mice, they were signifi-
cantly smaller compared to their wild-type littermates at 2
weeks after birth. This might be due to the severely
enlarged tongue and epithelial defects in tongue as well as
esophagus. The elevated basal keratinocytes proliferation
(about threefold increase) activity was associated with the
severely flaky skin surface and consistent with the micro-
scopic epidermal hyperkeratosis and acanthosis. While both
TGF-b and activin inhibit growth of basal cells, their
basal layer of epidermis of control sample. (B9) In Smad2 transgenic
corresponding to the expression pattern of Smad2 transgene. (C)
wild-type mice. (D) In Smad2 transgenic sample, the expression of
membrane.
FIG. 7. Abnormal upper and lower incisors in Smad2 transgenic m
well formed and the enamel surface appeared as shiny and smoot
appeared to be chalky-white and fragile (chipped easily, see inset in
cusps (m). Smad2 transgenic mice also had severely enlarged tongu
of the nose and upper and lower lip appeared shiny (arrow), which
corneum). (E, G) When the incisors were examined under scanning
magnification) of incisor (i) showed a smooth texture in the wild-ty
was rough and irregular (arrow). Scale bar 5 200 mm in (E) and (F).
IG. 8. Alteration of ameloblast organization and enamel matrix f
ere well organized to form enamel matrix, while odontoblasts (Od
meloblasts were not organized as well as in the wild-type control.
hich had resulted as the multiple cross-section appearance wh
ewborn wild-type mouse, amelogenin was expressed (arrow) in t
osterior part (p) of the incisor, ameloblasts were going through diffe
t higher magnification (E, 403), amelogenin was detected in the w
meloblasts. (D, F) In Smad2 transgenic mice, amelogenin was not
rganized ameloblasts (Amel).
Copyright © 2001 by Academic Press. All rightnatural expression in epidermis is predominately in supra-
basal differentiating layers, indicating their involvement in
maintaining the cessation of growth in the differentiating
cells of epidermis (Fuchs, 1990; Hubner et al., 1996). In vivo
functional studies, however, have revealed that both
TGF-b1 and activin A can inhibit or stimulate the prolif-
ration of basal keratinocytes, depending on the level of
heir expression in the epidermis (Sellheyer et al., 1993; Cui
t al., 1995; Fowlis et al., 1996; Munz et al., 1999). The
issue samples presented here were collected from hemizy-
ous Smad2 transgenic mice (by mating transgenic with
ild-type mice). When we used transgenic pairs to mate,
owever, a large number of newborns (n 5 32, possible
omozygous as determined by Southern blot analysis) died
t birth with tight skin surface (unpublished data). To date,
e have not been able to produce a litter of all transgenic
ups by crossing our K14-Smad2 with a wild-type mouse.
icroscopic analysis revealed that epidermis was ex-
remely thin with reduced basal cell proliferation in ho-
ozygous Smad2 transgenic mice. Clearly, the level of
mad2 expression is critical for mediating the inhibitory or
timulatory function of TGF-b in regulating the prolifera-
ion of basal keratinocytes.
Overexpression of Smad2 also altered the program of
eratinocytes differentiation. In particular, the boundaries
f each epidermal compartment, as defined by using
ifferentiation-specific protein markers, were disturbed
nd, consequently, there was significant overlap between
wo adjacent compartments. Keratin 14 expression ex-
ended into both suprabasal and granular layers of epider-
is, indicating that the keratinocytes enter an accelerated
ifferentiation process as they move toward the epidermal
urface while maintaining their basal cell characteristics.
xpanded K10 expression was detected in the suprabasal
le, TGF-b1 mRNA was present throughout all layers of epidermis,
onectin (Fibro) was localized within the connective tissue (*) of
ectin expanded into the dermis (d). Arrow points to the basement
A, C) In the wild-type control mice, incisors (i) and molars (m) were
2 weeks after birth. (B, D) In Smad2 transgenic mice, incisors (i)
The molars of Smad2 transgenic mice had fewer or less developed
that protruded between the upper and lower arch (B). Skin surface
lted from increased thickness of epidermis (especially the stratum
ron microscope the labial enamel surface (arrow in G, with higher
ice. (F, H) In Smad2 transgenic mice, the enamel surface of incisor
e bar 5 10 mm in (G) and (H).
tion in Smad2 transgenic animals. (A) At birth, ameloblasts (Amel)
had generated dentine matrix. (B) In the Smad2 transgenic sample,
rticular, ameloblasts were not positioned parallel with each other,
mpared with the control. (C, E) In mandibular cross-section of
amel matrix mainly in the anterior part (a) of the incisor. In the
iation and maturation process and were yet to produce amelogenin.
efined enamel matrix (e) at the apical region of the well-organized
ned within the enamel matrix (arrow) but was in between the lesssamp
Fibr
fibron
ice. (
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B).
e (t)
resu
elect
pe m
Scal
orma
ont)
In pa
en co
he en
rent
ell-d
confis of reproduction in any form reserved.
t
T
S
h
T
a
s
o
d
O
a
c
w
C
192 Ito et al.and granular layers of epidermis of Smad2 transgenic mice,
indicating that keratinocytes entered differentiation pro-
cess. As we examined the terminal differentiation of kera-
tinocytes by using both loricrin and filaggrin antibodies, we
found that the granular layer had expanded to overlap with
the suprabasal layer, again indicating an accelerated
keratinocyte-differentiation process in Smad2 transgenic
mice. These expanded patterns of K14, K10, loricrin, and
filaggrin expression are different from the ones in activin-
overexpressing transgenic mice, in which K14 and loricrin
expression is reduced in epidermis (Munz et al., 1999).
Despite the similarity in macroscopic phenotypes between
Smad2 and activin A transgenic mice, the alteration of
epidermal differentiation was quite different, which might
have resulted from the differential regulation of epidermal
homeostasis by different members of TGF-b family through
he selective activation of Smad2 or Smad3 in transducing
GF-b signaling.
TGF-b controls the proliferation of enamel organ epi-
thelium and regulates ameloblasts differentiation during
tooth morphogenesis (Vaahtokari et al., 1991; Coin et al.,
1999; Chai et al., 1999). Both Smad1 and Smad2 are
present in epithelially derived ameloblast and mesenchy-
mally derived odontoblasts, indicating that both BMP
and TGF-b are critical regulators during tooth develop-
ment (Dick et al., 1998). We have recently shown that
both positive and negative TGF-b signaling regulatory
mads are expressed during early tooth development and
aploinsufficiency of Smad2, but not Smad3, accelerated
GF-b-mediated tooth development (manuscript under
review). Here, overexpression of Smad2 did not block the
differentiation of ameloblasts, as demonstrated by the
production of amelogenin, but did alter the pattern of
ameloblasts assembly, deposition of amelogenin into
enamel extracellular matrix, and consequently affected
the topography of enamel surface.
We have not observed any skin abnormalities in Smad2
heterozygous mutant mice, which are maintained on the
same genetic background as our K14-Smad2 transgenic
mice. This is not surprising because about 30% of the
Smad21/2 mice died before birth, indicating that the level of
Smad2 is critical for the proper TGF-b signaling (Nomura
nd Li, 1998). Apparently, the Smad21/2 survivors have a
ufficient amount of Smad2 to carry out TGF-b-mediated
signaling events in the epidermis.
In conclusion, the concerted action of Smad2 and
Smad4 may selectively regulate TGF-b-mediated epider-
mal homeostasis and provide a positive feedback on the
endogenous TGF-b1 expression. The biological function
f Smad2 in mediating keratinocyte proliferation and
ifferentiation is sensitive to the level of its expression.
ur in vivo Smad2 functional analysis provides invalu-
ble information toward a better understanding of the
omplexity of TGF-b-mediated homeostatic equilibrium
ithin the skin.
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